CXCR4 and Alzheimer disease: More recently, the ratio between C-X-C chemokine receptor type 4 (CXCR4)+ harmful and hyperactive neutrophils to CD62L+ senescent neutrophils and the levels of ROS in blood were found significantly higher in AD patients with severe dementia when compared to mild cognitive impairment (MCI) patients (100).